<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders">Surgical Margins (CoC)<br/>Residual Primary Tumor Following Cancer-Directed Surgery (pre-96 CoC)<br/></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1320</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1574 - 1574</td>
    </tr>
</table>

<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para'>Codes describe the final status of surgical margins after resection of the primary tumor. See also RX Summ--Surg Prim Site [1290].</div>
<div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div>
<div class='content chap10-para'>This item serves as a quality measure for pathology reports, is used for staging, and may be a prognostic factor in recurrence. This item is not limited to cases that have been staged. It applies to all cases that have a surgical procedure of the primary site.</div>
<div class='content chap10-para'><strong>Codes (Refer to the most recent version of <em>FORDS</em> for additional instructions.) </strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>0</td>
            <td class='code-desc'>No residual tumor</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>1</td>
            <td class='code-desc'>Residual tumor, NOS</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>2</td>
            <td class='code-desc'>Microscopic residual tumor</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>3</td>
            <td class='code-desc'>Macroscopic residual tumor</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>7</td>
            <td class='code-desc'>Margins not evaluable</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>8</td>
            <td class='code-desc'>No primary site surgery</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>9</td>
            <td class='code-desc'>Unknown or not applicable</td>
        </tr>
    </table>
</div>
<div class='content chap10-para'><em>Note:</em> Codes were site specific (1998-2002), and have been changed to be generic across all disease sites.</div>